| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A9JQZ1 | UDP-glucuronosyltransferase 1A8; Fragment; | UGT1A8; | NULL | 286 | human |
| H0UIA7 | Chromosome 20 open reading frame 118, isoform CRA_a; | C20orf118; | NULL | 163 | human |
| B7Z4Y8 | Butyrophilin-like protein 9; cDNA FLJ52190, highly similar to Butyrophilin-like protein 9; | BTNL9; | NULL | 246 | human |
| Q4F050 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A1DU19 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| B8X5K0 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| E5DYN0 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| Q50KF9 | Taste receptor type 2; Fragment; | Hosa(Japanese)-T2R48; Hosa(Adygei)-T2R48; | NULL | 280 | human |
| A0A023QYQ2 | Cytochrome b; | CYTB; | NULL | 380 | human |
| Q496K8 | SLC2A11 protein; Solute carrier family 2 (Facilitated glucose transporter), member 11, isoform CRA_b; | SLC2A11; | NULL | 213 | human |
| F2WE38 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| A0A087WWT6 | Protein CBFA2T1; Runt-related transcription factor 1 translocated to, 1 (Cyclin D-related), isoform CRA_c; | RUNX1T1; | NULL | 584 | human |
| D3DSM6 | Folate transporter 1; Solute carrier family 19 (Folate transporter), member 1, isoform CRA_f; | SLC19A1; | NULL | 613 | human |
| A0SBM6 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; NADH1; | NULL | 318 | human |
| S5LQX7 | Cellular tumor antigen p53; Fragment; | TP53; | NULL | 115 | human |
| A4ZLI1 | Cytochrome b; | CYTB; | NULL | 380 | human |
| V5JQE6 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| Q6FIB4 | F11 receptor; F11 receptor protein; F11 receptor, isoform CRA_c; F11R protein; JAM1; cDNA FLJ90671 fis, clone PLACE1005544, highly similar to Junctional adhesion molecule 1; | F11R; | NP_058642.1; | 299 | human |
| B4E009 | Early activation antigen CD69; cDNA FLJ55409, highly similar to Early activation antigen CD69; | CD69; | NULL | 164 | human |
| Q6RRL1 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |